Dyslipidämie, vorbehandelte Patienten
G-BA action
final resolution
2022-05-05
Evidence-checked summary
The G-BA issued a final resolution on 2022-05-05. The official page states that it took effect as follows: 05.05.2022. The page lists Arzneimittel-Richtlinie, Anlage XII: Nutzenbewertung nach § 35a SGB V as the normative target.
This is the latest validated public action attached to this case. It is separate from the IQWiG assessment result.
Final benefit result
Patient group
Erwachsene mit erhöhten Triglyzeriden (≥ 150 mg/dl) und hohem kardiovaskulärem Risiko zur Senkung des Risikos kardiovaskulärer Ereignisse
Added benefit not proven
Comparator
- Therapie nach ärztlicher Maßgabe unter Berücksichtigung von Statinen und Cholesterinresorptionshemmern
Official case record
No inferred stages
Consultation record
2022-01-10
71 parsed turns
Oral hearing: Icosapent-Ethyl (Dyslipidämie, vorbehandelte Patienten)
Official Wortprotokoll · 15 pages
IQWiG comparison
IQWiG assessment findings and the later G-BA action are separate records. Open both to compare them.
A21-113
matched
Icosapent ethyl (hypertriglyceridaemia) - Benefit assessment according to §35a Social Code Book V
Official assessment PDF · 52 pages
G-BA decisions
2022-02-17
final resolution
The G-BA found no proven added benefit for Erwachsene mit erhöhten Triglyzeriden (≥ 150 mg/dl) und hohem kardiovaskulärem Risiko zur Senkung des Risikos kardiovaskulärer Ereignisse. The appropriate comparator was - Therapie nach ärztlicher Maßgabe unter Berücksichtigung von Statinen und Cholesterinresorptionshemmern. The G-BA issued a final resolution on 2022-02-17. The official page states that it took effect as follows: 17.02.2022. The page lists Arzneimittel-Richtlinie, Anlage XII: Nutzenbewertung nach § 35a SGB V as the normative target.
4 official documents · 4 cited claims
2022-05-05
final resolution
The G-BA issued a final resolution on 2022-05-05. The official page states that it took effect as follows: 05.05.2022. The page lists Arzneimittel-Richtlinie, Anlage XII: Nutzenbewertung nach § 35a SGB V as the normative target.
3 official documents · 3 cited claims
Official sources